Department of Defense (DOD) Fiscal Year 2006 (FY06) Prostate Cancer Research Program (PCRP) New Investigator Award
The summary for the Department of Defense (DOD) Fiscal Year 2006 (FY06) Prostate Cancer Research Program (PCRP) New Investigator Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
Department of Defense (DOD) Fiscal Year 2006 (FY06) Prostate Cancer Research Program (PCRP) New Investigator Award: The intent of the PCRP New Investigator Award is to recognize and support independent investigators in the early stages of their careers. The PCRP seeks investigators who have innovative, high-impact ideas or new technologies applicable to prostate cancer research or treatment. New investigators are defined as being within 6 years of completing their last fellowship or postdoctoral position. Applicants may not have received non-mentored research funding in excess of $100,000 in direct costs in aggregate from extramural sources as a Principal Investigator (PI) or co-PI. Four important features of this award mechanism are: (1) innovation; (2) impact; (3) a requirement for a collaborator with experience in prostate cancer research; and (4) no requirement for preliminary data. 1. Innovation: Innovation is a significant feature of the New Investigator Award. Research deemed innovative may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives. It is the responsibility of the applicant to clearly and explicitly articulate how the proposed research is innovative. Proposals may be innovative in a variety of ways, including: Study concept - investigation of a novel idea and/or unique research question that has the potential to advance the field of prostate cancer research in a significant way. Research method or technology - use of novel research methods or new technologies to address a research question that could not be addressed using conventional methods/techniques. Clinical interventions - use of a novel method or technology for preventing, diagnosing, or treating prostate cancer. Adaptations of existing methods or technologies - application or adaptation of existing methods or technologies for research or clinical purposes that are fundamentally different from those originally intended, and/or for use in novel research or clinical purposes. This list is intended to serve as a foundation on which to frame and present the innovative features of the proposal. Conversely, examples of research that is not innovative and will not be considered for funding under this mechanism include: Exploring a hypothesis in a different cell line. Using a published series of in vitro assays to further characterize a model system. Incorporating known biomarkers into in vitro or clinical models of prostate cancer. 2. Impact: Research that has high impact may significantly advance current methods, concepts, prevention, diagnosis, or treatment of prostate cancer or quality of life for patients. It is the responsibility of the applicant to clearly and explicitly articulate the impact the proposed research may have on the field of prostate cancer research. 3. Collaborator: Submission to this award mechanism requires a collaborator (or collaborators) from an appropriate discipline (clinical research, pathology, urology, etc.) who has experience in prostate cancer research. He or she must have a demonstrated record of funding and publications in prostate cancer research. 4. Preliminary Data: In accordance with the challenge to be innovative and capture novel ideas in their early stages of development, proposals are not required to have preliminary data. Although this research is inherently risky, these proposals should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature.
Federal Grant Title: | Department of Defense (DOD) Fiscal Year 2006 (FY06) Prostate Cancer Research Program (PCRP) New Investigator Award |
Federal Agency Name: | Dept of the Army USAMRAA |
Grant Categories: | Science and Technology |
Type of Opportunity: | Mandatory |
Funding Opportunity Number: | W81XWH-06-PCRP-NIA |
Type of Funding: | Cooperative Agreement Grant |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Military Medical Research and Development |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Apr 18, 2006 Deadline for submittals is 5:00PM Ea |
Posted Date: | Feb 01, 2006 |
Creation Date: | Feb 01, 2006 |
Archive Date: | May 18, 2006 |
Total Program Funding: | $8,000,000 |
Maximum Federal Grant Award: | $225,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 24 |
Cost Sharing or Matching: | Yes |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Joseph Little
Contract Specialist
Phone 301-619-2546 [email protected] Email for POC for this synopsis - Similar Government Grants
- • DoD Peer Reviewed Medical, Impact Award
- • DoD Peer Reviewed Medical, Lifestyle and Behavioral Health Interventions Research Award
- • DoD Peer Reviewed Medical, Discovery Award
- • DoD Peer Reviewed Medical, Technology/Therapeutic Development Award
- • DoD Peer Reviewed Medical, Clinical Trial Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • Spinal Cord Injury Research Program Clinical Translation Research Award
- • Spinal Cord Injury Research Program Clinical Trial Award
- • DoD Hearing Restoration Focused Research Award
- • DOD Spinal Cord Injury Research Program Translational Research Award
- • DoD Autism, Clinical Trial Award